Reshma Kewalramani's Net Worth
$119 Million
Who is Reshma Kewalramani?
Reshma Kewalramani has an estimated net worth of $119 Million. This is based on reported shares across multiple companies, which include VERTEX PHARMACEUTICALS INC / MA, and Ginkgo Bioworks Holdings, Inc..
SEC CIK
Reshma Kewalramani's CIK is 0001735944
Past Insider Trading and Trends
2021 was Reshma Kewalramani's most active year for acquiring shares with 8 total transactions. Reshma Kewalramani's most active month to acquire stocks was the month of January. 2020 was Reshma Kewalramani's most active year for disposing of shares, totalling 47 transactions. Reshma Kewalramani's most active month to dispose stocks was the month of January. 2023 saw Reshma Kewalramani paying a total of $3,115,592.87 for 330,736 shares, this is the most they've acquired in one year. In 2024 Reshma Kewalramani cashed out on 188,018 shares for a total of $37,205,763.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468
CEO & President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -14.32% | -15.20K |
$505.00 | -$7,677,010.00 | 90.97K |
Scheduled
|
Jul 30
| ||
Form 4
| -12.52% | -15.20K |
$497.00 | -$7,555,394.00 | 106.17K |
Scheduled
|
Jul 22
| ||
Form 4
|
—
|
0
|
$322.27 | -$421,720.55 | 121.37K |
Scheduled
|
May 24
| ||
Form 4
| -11.13% | -15.20K |
$447.00 | -$6,795,294.00 | 121.37K |
Scheduled
|
May 20
| ||
Form 4
| -6.43% | -9.39K |
$431.79 | -$4,052,780.94 | 136.51K |
Feb 23
| |||
Form 4
| -10.09% | -16.38K |
$422.54 | -$6,920,360.61 | 145.89K |
Feb 16 - Feb 20
| |||
Form 4
| -4.84% | -8.26K |
$422.74 | -$3,489,718.70 | 162.27K |
Feb 9
| |||
Form 4
| +56.86% | 61.81K |
—
|
—
| 170.53K |
Feb 6 - Feb 7
| |||
Form 4
|
—
|
0
|
$294.42 | -$3,858,352.13 | 108.71K |
Scheduled
|
Dec 15
| ||
Form 4
| -4.48% | -5.10K |
$397.00 | -$2,023,906.00 | 108.71K |
Scheduled
|
Dec 13
| ||
Form 4
| -4.29% | -5.10K |
$377.00 | -$1,921,569.00 | 113.81K |
Scheduled
|
Nov 13
| ||
Form 4
| -6.18% | -7.83K |
$355.00 | -$2,778,940.00 | 118.91K |
Jul 17
| |||
Form 4
| -2.55% | -3.32K |
$339.08 | -$1,124,726.05 | 126.65K |
Apr 27
| |||
Form 4
| -6.74% | -9.39K |
$289.12 | -$2,713,680.32 | 129.97K |
Feb 24
| |||
Form 4
| -6.29% | -9.36K |
$292.85 | -$2,740,783.15 | 139.35K |
Feb 17
| |||
Form 4
| -5.92% | -9.36K |
$296.84 | -$2,779,058.16 | 148.71K |
Feb 10 - Feb 13
| |||
Form 4
| +76.43% | 68.48K |
—
|
—
| 158.08K |
Feb 1
| |||
Form 4
| -10.04% | -10.00K |
$315.05 | -$3,150,500.00 | 89.6K |
Scheduled
|
Jan 25
| ||
Form 4
| -10.50% | -11.69K |
$305.06 | -$3,565,846.34 | 99.6K |
Scheduled
|
Aug 15
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -9.52% | -11.69K |
$291.30 | -$3,405,005.70 | 111.15K |
Scheduled
|
Jun 24
| ||
Form 4
| -5.57% | -7.25K |
$227.86 | -$1,651,073.56 | 122.84K |
Feb 24
| |||
Form 4
| -6.19% | -8.58K |
$232.51 | -$1,995,865.84 | 130.09K |
Feb 17
| |||
Form 4
| -2.14% | -3.03K |
$237.74 | -$720,589.94 | 138.67K |
Feb 10
| |||
Form 4
| +92.13% | 67.95K |
—
|
—
| 141.7K |
Feb 1
| |||
Form 4
| +15.69% | 10K |
$195.65 | $1,956,491.60 | 73.75K |
Aug 19
| |||
Form 4
| -4.36% | -2.90K |
$217.57 | -$630,517.86 | 63.64K |
Feb 24
| |||
Form 4
| -3.03% | -2.08K |
$211.75 | -$440,440.00 | 66.54K |
Feb 17
| |||
Form 4
| -4.14% | -2.96K |
$214.16 | -$634,341.92 | 68.62K |
Feb 10
| |||
Form 4
| +168.62% | 44.94K |
—
|
—
| 71.58K |
Feb 3
| |||
Form 4
|
—
|
0
|
$225.44 | -$189,722.92 | 26.63K |
Scheduled
|
Aug 6
| ||
Form 4
| -0.37% | -99.00 |
$284.17 | -$28,132.46 | 26.63K |
Scheduled
|
May 15
| ||
Form 4
|
—
|
0
|
$226.26 | -$193,244.52 | 26.63K |
Scheduled
|
May 6
| ||
Form 4
| -19.70% | -6.53K |
$236.02 | -$1,541,659.73 | 26.63K |
Scheduled
|
Feb 24 - Feb 25
| ||
Form 4
| -6.03% | -2.13K |
$242.62 | -$516,045.99 | 33.16K |
Scheduled
|
Feb 17 - Feb 18
| ||
Form 4
| +137.72% | 18.04K |
$209.56 | -$869,237.13 | 35.28K |
Scheduled
|
Feb 5 - Feb 6
| ||
Form 4
|
—
|
0
|
$203.45 | -$149,393.28 | 13.1K |
Scheduled
|
Nov 25
| ||
Form 4
| -0.46% | -61.00 |
$205.95 | -$12,562.95 | 13.1K |
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
$177.29 | -$22,105.87 | 13.1K |
Scheduled
|
Nov 8
| ||
Form 4
|
—
|
0
|
$177.29 | -$132,765.51 | 13.1K |
Scheduled
|
Oct 30
| ||
Form 4
| -4.64% | -638.00 |
$189.00 | -$120,582.00 | 13.1K |
Scheduled
|
Oct 22
| ||
Form 4
| -1.72% | -241.00 |
$165.41 | -$39,863.81 | 13.74K |
Scheduled
|
May 15
| ||
Form 4
| -9.77% | -1.49K |
$186.94 | -$278,163.04 | 13.74K |
Scheduled
|
Feb 19
| ||
Form 4
| +697.49% | 13.31K |
—
|
—
| 15.22K |
Feb 6
| |||
Form 4
| -54.70% | -2.31K |
$186.95 | -$430,919.75 | 1.91K |
Scheduled
|
Oct 8
| ||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ginkgo Bioworks Holdings, Inc. (DNA) Snapshot price: $5.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +130.37% | 105.26K |
—
|
—
| 186K |
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +13.84% | 9.82K |
—
|
—
| 80.74K |
Sep 30
| |||
Form 4
|
∞
| 70.92K |
—
|
—
| 70.92K |
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||